ClinicalTrials.gg
RecruitingNCT07482150Updated Oct 7, 2026

The Connect Trial: Connecting Hospital Patients to Alcohol Care

An interventional study of AUD treatment sessions with an outreach alcohol therapist at the hospital and Guidance and leaflet on AUD treatment facilities outside the hospital in Alcohol Use Disorder, sponsored by Zealand University Hospital. Recruiting at 1 site in Denmark. Open to participants aged 18 Years to 99 Years. Per ClinicalTrials.gov, last updated 2026-10-07.

Sponsored by Zealand University Hospital · Not applicable, Interventional, and Prevention

How we know

From the registry’s dates

  • Started Mar 2026; still recruiting 8 months later.
Updated Oct 7, 2026Now RecruitingSite recruiting status changed+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years to 99 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 29 studies in Alcoholism with a site in Denmark — 7 open to participants now, 11 under way, none of them phase 3. Alcoholism · Denmark.

Planned enrollment
19th of 29
60 · median 113
Started
2026
the only one that year
No phase
17 of 29
6 open now
Primary completion
2027-09
later than 6 of 10 live
Registered
28th of 29
by date
Lead sponsor
3 of 29
Zealand University Hospital

Among the 29 studies in Alcoholism with a site in Denmark, this one is the 19th largest by planned enrollment, is the only one that started in 2026, is one of 17 with no phase, reaches primary completion later than 6 of the 10 other live ones, and was the 28th registered.

Alcoholism

1,679 studies on the registry are indexed under Alcoholism; 333 are open to participants now.

Browse Alcoholism studies →

Open to participants now

7 of the 29 studies in Alcoholism with a site in Denmark are open now. Recruiting first, the newest first:

1 more — sign in →

All 7 open studies →

A study can be open while its sites in Denmark have not opened yet or have stopped. Only those recruiting at a site in Denmark →

Who these studies take

Of the 238 Alcoholism studies recruiting now, 85 (36%) set no upper age limit and 131 (55%) stop at 75 or younger; 9 take children under 18; 64 take healthy volunteers.

This study: 18 Years to 99 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 29 studies in Alcoholism with a site in Denmark, or all of them as a file.
02

Study summary

The main objective of this pilot study is to assess feasibility of conducting a definitive RCT with concealed allocation, blinded outcome assessment and a 1:1 parallel group design of A) an invitation to meet an AUD therapist for up to 10 treatment sessions at the hospital in up to 6 months (intervention) compared to B) guidance on how to seek alcohol care in an AUD treatment centre in the community, outside of the hospital (control).

03

Conditions studied

  • Alcohol Use Disorder

Browse trials for

Keywords

  • alcohol misuse treatment
  • inhospital alcohol care
  • pilot study
  • implementation study
04

Who can participate

Ages eligible
18 Years to 99 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Hospitalised or seen in an outpatient clinic at SUH Køge
  • Full-filling international classification of disease version 10: F102: alcohol dependence or F101: harmful alcohol use
  • Informed written consent
  • Being able to meet the AUD therapist in connection with a hospital visit with a health condition wholly or partly attributable to alcohol

Exclusion criteria

Exclusion Criteria:

  • Ongoing specialized treatment for AUD
  • Not speaking Danish
  • Not living in the catchment area of Zealand University hospital
  • Age \< 18 years
  • Enrolled in the Zealand alcohol-related liver disease cohort study
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • Active comparator
    Control group

    Participants randomised as controls will be offered a leaflet informing about different possibilities for alcohol misuse treatments and guidance on how to approach them (may include referral or help with doing an appointment, if possible according to the specific treatment center) in the catchment area of SUH Køge and Roskilde.

    Other: Guidance and leaflet on AUD treatment facilities outside the hospital

  • Experimental
    Intervention group

    Participants will be offered an AUD treatment session at the hospital the same or next day as they are enrolled in the study with an outreach alcohol therapist from a local AUD treatment facility. The alcohol therapist will be trained in motivational interviewing and cognitive behavioural therapy for AUD. The session will last for 20 to 60 minutes and can take place either at the department where the patient is admitted or elsewhere to ensure confidentiality. Up to 10 sessions at the hospital during 6 months after the baseline visit can be offered and after that, the participant can continue to meet with the same therapist in the community alcohol treatment facility. The participant will also be informed about other options for specialised alcohol treatment, group therapy, peer support and self-help groups.

    Other: AUD treatment sessions with an outreach alcohol therapist at the hospital

Interventions

  • OtherAUD treatment sessions with an outreach alcohol therapist at the hospital

    Participants will be offered an AUD treatment session at the hospital the same or next day as they are enrolled in the study with an outreach alcohol therapist from a local AUD treatment facility. The alcohol therapist will be trained in motivational interviewing and cognitive behavioural therapy for AUD. The session will aim to motivate patients to reduce their alcohol consumption and set goals for AUD treatment. The alcohol therapist can recommend a medical therapy to support alcohol reduction or abstinence - this prescription will be undertaken by a hepatologist from the Department of Medicine and may be continued after discharge by patients´ general practitioner or physicians at the AUD treatment facility. Up to 10 sessions of up to 60 minutes of duration at the hospital during 6 months after the baseline visit can be offered and after that, the participant can continue to meet with the same therapist in the community.

  • OtherGuidance and leaflet on AUD treatment facilities outside the hospital

    Participants randomised as controls will be offered a leaflet informing about different possibilities for alcohol misuse treatments and guidance on how to approach them (may include referral or help with doing an appointment, if possible according to the specific treatment center) in the catchment area of SUH Køge and Roskilde

06

What researchers measure

Primary outcomes

  1. Recruitment

    \>50% of eligible individuals invited to the study give written informed consent

    Time frame: 6 months

  2. Retention

    \>50% individuals recruited and randomized to the intervention, will attend to the intervention of seing the AUD therapist at least once

    Time frame: 6 months

  3. Completion

    \>50% of all randomized study participants complete the follow-up interview and blood sample

    Time frame: 6 months

Secondary outcomes

  1. AUD treatment engagement after 6 and 12 months

    No predefined goal

    Time frame: 12 months

  2. Mortality after 6 and 12 months

    No predefined goal

    Time frame: 12 months

  3. Change in drinks (containing 12 g ethanol) per last 30 days from baseline till 6 months after inclusion

    Time frame: 6 months

  4. Proportion with abstinence or light drinking (<10 drinks/week) last 30 days

    yes or no

    Time frame: 6 months

  5. Change in blood phosphatidyl ethanol level from baseline to 6 months after inclusion

    Time frame: 6 months

  6. Change in motivation to cut down on alcohol (yes or no), calculated as the difference between baseline and 6 months follow-up

    Time frame: 6 months

  7. Number of AUD treatment sessions

    Time frame: 6 months

  8. Proportion initiating medical AUD therapy

    Time frame: 6 months

  9. Proportion receiving medical AUD treatment at 6- and 12 months follow up

    Time frame: 12 months

  10. Number of acute hospital admissions or emergency room visits at 6 and 12 months

    Time frame: 12 months

  11. Number of hospital outpatient visits at 6 and 12 months

    Time frame: 12 months

  12. 3- year follow-up, conducted through health care registries and AUD treatment facilities to look for incidence of alcohol-related morbidity and mortality, visits to general practitioner and hospital contacts

    Time frame: 3 years

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Schwarz AS, Nielsen B, Sogaard J, Sogaard Nielsen A. Making a bridge between general hospital and specialised community-based treatment for alcohol use disorder-A pragmatic randomised controlled trial. Drug Alcohol Depend. 2019 Mar 1;196:51-56. doi: 10.1016/j.drugalcdep.2018.12.017. Epub 2019 Jan 17. PubMed 30665152 ↗
  • Incze MA, Kelley AT, James H, Nolan S, Stofko A, Fordham C, Gordon AJ. Post-hospitalization Care Transition Strategies for Patients with Substance Use Disorders: A Narrative Review and Taxonomy. J Gen Intern Med. 2024 Apr;39(5):837-846. doi: 10.1007/s11606-024-08670-5. Epub 2024 Feb 27. PubMed 38413539 ↗

Individual participant data

Plan to share: No

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2026 (actual). Primary completion is estimated for Sep 2027, 17 months after the start.

Of 472 non-industry interventional studies with no phase under Alcoholism, half reached primary completion within 35 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 54. This study's planned 17 months is below that.

Counting every sponsor, half of 495 studies reached it within 33 months; a quarter within 17 and three quarters within 52.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 9, 2026
First posted
Mar 19, 2026
StartActual
Mar 15, 2026
Primary completionEst.
Sep 1, 2027
CompletionEst.
Sep 1, 2031
Last update
Oct 7, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Oct 7, 2026
Sites
Zealand University Hospital, Department of Medicine is now Recruiting
Oct 7, 2026
Start date
Mar 10, 2026→Mar 15, 2026 (actual)
Oct 7, 2026
Site contacts
Changed at 1 site. See the sites
Show the site
  • Zealand University Hospital, Department of Medicine · Køge, DenmarkContact added g•••@regionsjaelland.dk · •••9981
Oct 7, 2026
Show all 1 update
  1. Oct 7, 2026
    Not yet recruiting→Recruiting
    Zealand University Hospital, Department of Medicine is now Recruiting
    Start date Mar 10, 2026→Mar 15, 2026 (now actual)
    Site contacts Changed at 1 site. See the sites
    Show the site
    • Zealand University Hospital, Department of Medicine · Køge, DenmarkContact added g•••@regionsjaelland.dk · •••9981
    + 2 other changes: verification date and oversight details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07482150
Responsible party
Gro Askgaard (MD PhD, Zealand University Hospital) — Principal investigator
First posted
Mar 19, 2026
Start date
Mar 15, 2026
Primary completion
Sep 1, 2027 (estimated)
Completion
Sep 1, 2031 (estimated)
Last update
Oct 7, 2026

Study contacts

Gro Askgaard, MD, PhD
Contact
gras@regionsjaelland.dk
60142280
Gro Askgaard
principal investigator · Sjaellands Universitetshospital Køge, Medicinsk Afdeling

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion